Mianserin < Mice < Mice, Inbred BALB C

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 63.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000081 (1999)	E. Grünblatt [Israël] ; S. Mandel ; T. Berkuzki ; M B Youdim	Apomorphine protects against MPTP-induced neurotoxicity in mice.
000158 (1999)	F. Cardozo-Pelaez [États-Unis] ; S. Song ; A. Parthasarathy ; C. Hazzi ; K. Naidu ; J. Sanchez-Ramos	Oxidative DNA damage in the aging mouse brain.
000262 (2000)	L C Abbott [États-Unis] ; M. Bump ; A. Brandl ; S. De Laune	Investigation of the role of the cerebellum in the myoclonic-like movement disorder exhibited by tottering mice.
000281 (2000)	H A Jinnah [États-Unis] ; J P Sepkuty ; T. Ho ; S. Yitta ; T. Drew ; J D Rothstein ; E J Hess	Calcium channel agonists and dystonia in the mouse.
000347 (2000)	R J Carter [Royaume-Uni] ; M J Hunt ; A J Morton	Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene.
000353 (2000)	D. Dressler [Royaume-Uni] ; G. Dirnberger ; K P Bhatia ; A. Irmer ; N P Quinn ; H. Bigalke ; C D Marsden	Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay.
000458 (2001)	H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C Hirsch	Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000577 (2001)	M. Pandolfo [Canada]	Molecular basis of Friedreich ataxia.
000835 (2002)	Johannes Schiefer [Allemagne] ; G Bernhard Landwehrmeyer ; Hans-Gerd Lüesse ; Arne Sprünken ; Christiane Puls ; Anna Milkereit ; Eva Milkereit ; Christoph M. Kosinski	Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease.
000991 (2003)	Peter Teismann [États-Unis] ; Kim Tieu ; Oren Cohen ; Dong-Kug Choi ; Du Chu Wu ; Daniel Marks ; Miquel Vila ; Vernice Jackson-Lewis ; Serge Przedborski	Pathogenic role of glial cells in Parkinson's disease.
000A92 (2003)	Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi	Models of Parkinson's disease.
000B89 (2003)	George R. Uhl [États-Unis]	Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.
000C95 (2004)	Paul J. Lockhart [États-Unis] ; Casey A. O'Farrell ; Matthew J. Farrer	It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG).
000D66 (2004)	Dorothy D. Whelchel [États-Unis] ; Tonia M. Brehmer ; Paula M. Brooks ; Neely Darragh ; Julie A. Coffield	Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
000D70 (2004)	John A. Chaddock [Royaume-Uni] ; John R. Purkiss ; Frances C G. Alexander ; Sarah Doward ; Sarah J. Fooks ; Lorna M. Friis ; Yper H J. Hall ; Elizabeth R. Kirby ; Nicola Leeds ; Hilary J. Moulsdale ; Anthony Dickenson ; G Mark Green ; Wahida Rahman ; Rie Suzuki ; Michael J. Duggan ; Conrad P. Quinn ; Clifford C. Shone ; Keith A. Foster	Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
000D71 (2004)	Leonard A. Smith [États-Unis] ; Melody J. Jensen ; Vicki A. Montgomery ; Douglas R. Brown ; S Ashrat Ahmed ; Theresa J. Smith	Roads from vaccines to therapies.
000F01 (2004)	Bernhard Voller [Autriche] ; Ekaterina Moraru ; Eduard Auff ; Michael Benesch ; Werner Poewe [Autriche] ; Jörg Wissel ; Jörg Müller ; Tanja Entner ; Hans Bigalke ; Peter Schnider	Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type A.
001103 (2005)	Fredricka C. Martin [États-Unis] ; Anh Thu Le ; Adrian Handforth	Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications.
001129 (2005)	H A Jinnah [États-Unis] ; Ellen J. Hess ; Mark S. Ledoux ; Nutan Sharma ; Mark G. Baxter ; Mahlon R. Delong	Rodent models for dystonia research: characteristics, evaluation, and utility.
001180 (2005)	Katharina Diepold [Allemagne] ; Barbara Schütz ; Kevin Rostasy ; Bernd Wilken ; Pia Hougaard ; Flemming Güttler ; Anne Romstad ; Lisbeth Birk M Ller	Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.
001308 (2005)	Jason D. Dapper [États-Unis] ; Monica J. Justice	Defining the breakpoints of the quaking(viable) mouse mutation reveals a duplication from a Parkin intron.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Mice" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Mice" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Mice
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024